Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GreenVision Acquisition Corp. was a Special Purpose Acquisition Company (SPAC) formed in 2019. Although it initially stated its intention to focus on target businesses in the life sciences and healthcare industries, it ultimately completed a $300 million business combination with Helbiz, Inc., a micro-mobility services company, in August 2021. Following the merger, GreenVision ceased to exist, and the combined entity began trading as Helbiz, Inc.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GreenVision Acquisition Corp..